Q&A for Group Administrators: Wellmark Announces Strategic Pharmacy Program Changes to Help Control Drug Spend
|
|
- Lewis Hutchinson
- 6 years ago
- Views:
Transcription
1 Learn More Q&A for Group Administrators: Wellmark Announces Strategic Pharmacy Program Changes to Help Control Drug Spend Iowa and South Dakota Pharmacy Benefit Plans This document answers questions regardingupcoming pharmacy tier changes, and updates for hightrend/high-spend drugsand compounds designed tocontrol drug spend. Wellmark will introduce strategic pharmacy program changes designed to control drug spend beginning July Q: Why is Wellmark changing some pharmacy programs? A: Drug spend is rising at a rapid and unsustainable rate. Addressing these cost trends is crucial to assuring a sustainable health care system and managing costs. Q: Whatprograms will change? A: Fiveareas will be impacted: 1. July formulary changes 2. Specialty drug 3. Insulin utilization management 4. ADHD utilization management 5. Compound management July formulary changes Q: Why is Wellmark making formulary changes? A: To help control costs for members, we regularly update the Wellmark Drug List of covered drugs with a committee of statewide pharmacists and physicians. Sometimes, the cost share for certain drugs may change. This means there will be changes that may affect pharmacy costs and coverage. Q: Whenwill theformulary changes become effective? A:July 31, Q: What drugs are impacted by the formulary changes? A:Below is an overview of the July formulary changes: 6/15 Page 1 of 7
2 Drugs moving to a lower tier Drug name Future tier Advair Diskus 2 Advair HFA 2 AsmanexHFA 1 Astagraf XL 2 Eliquis 2 Janumet 2 Janumet XR 2 Jentadueto 2 Levemir 2 LevemirFlexpen 2 LevemirFlextouch 2 Pradaxa 2 Tradjenta 2 Victoza 2 Drugs moving to the highest tier or removed from formulary Actoplus MET XR Cambia Humulin Android Elidel Menest Apidra Femring Nasonex Avandia Gralise Proventil HFA Bethkis Horizant Ventolin HFA Binosto Humalog/Humalog Mix Vimovo Brisdelle Drugs no longer covered First-Omeprazole Fluoride Products 6/15 Page 2 of 7
3 Drugs moving from tier 1 to tier 2 Estrace Drugs moving from tier 2 to tier 3 Byetta Elmiron Epzicom Multaq Ranex Drugs moving from tier 3 to specialty preferred Kuvan Q:How do I find a list of drugs on the different tiers? A: The Wellmark Drug List is updated regularly on Wellmark.com. The Drug List is on the right side of the home page under Quick Links. The Wellmark Drug Listshows what tier a drug is on, information about the drug and possible drug options. Q: Whatoptions do my employees have if they are impacted by these changes? A: Wellmark and your account representative are here to help. Below are options they may consider: 1. Look for different options for the medication. Members may visit Wellmark.com and look for thedrug on the Wellmark Drug List to see the drug s tier and a list of possible lower-cost options. 2. Contact the physician who prescribed the drug to get a new prescription to move to a generic or another alternative medication. If a generic alternative is available, and these drugs are approved by the FDA to treat the illness or condition, the member will pay a lower out-of-pocket amount. 3. Members may keep taking the drug, but if they do, they will pay the higher cost share. To see the full cost of the drug, members may log in to mywellmark.com and click on the Prescriptions Drugs tab, and then click Wellmark Drug List (Price & Save Tool) in the Prescription Drug Tools box.members may also call your pharmacist for the drug cost. Specialty drug program changes Q: What are thespecialty drug program changes, and when will they be effective? A:Specialty drugs are the fastest growing and most expensive segment in pharmacy today and 6/15 Page 3 of 7
4 encompassed 28 percent of Wellmark s total drug cost in Wellmark expanded our specialty drug program to the following conditions to manage the increasing cost. Condition Drug Changes Effective Date Hepatitis C Chronic inflammatory disease Multiple sclerosis Wellmark will implement a preferred drug strategy with Harvoni and Solvaldi for treatment of hepatitis C. Viekira Pak and Olysio will be added as non-preferred therapies and will require the use of the preferred drugs. Non-preferred therapies will move to the nonpreferred specialty tier on the formulary. To help control member costs, Wellmark will add Entyvio as a non-preferred therapy to the tumor necrosis factor (TNF)-α inhibitor preferred drug plan design. We will alsorequire trials of both preferred TNF-α inhibitors, Enbrel and Humira, for all non-preferred therapies in patients with a diagnosis for which both products are indicated. This includes Humira as the preferred drug for pediatric Crohn s Disease. To create cost savings for our members, Wellmark will update the multiple sclerosis (MS) utilization management program to require prior authorization for all MS drugs, including orals. Wellmark will update the preferred drug plan design to include Avonex, Aubagio, Rebif, Tysabri and Lemtrada as nonpreferred therapies. Trials of two out of the five preferred therapies, Copaxone 20mg, Extavia, Gilenya, Plegridy and Tecfidera, will now be required. July 1, 2015 for new users (changes will not affect current users) July 1, 2015 for new users (changes will not affect current users) August 1, 2015 for new users (changes will not affect current users) Q: What can I, as an employer, do to address the rapidly expanding specialty drug market? A:Wellmark offers a comprehensive specialty drug management program that you should consider implementing for the upcoming plan year. The program has three components: 1. Ensure specialty drugs are covered under your pharmacy benefit. 6/15 Page 4 of 7
5 2. Limit specialty drug distribution. 3. Implement a preferred specialty drug strategy. Please speak to your Wellmark representative to learn more. Insulin utilization management changes Q: What insulin program areas will be impacted, and when will they be effective? A: With no generic or biosimilar availability for insulin and to keep our members costs controlled Wellmark is implementing the following management strategy: Management Strategy Insulin tier change Require prior authorization Convert to preferred testing product Changes Non-preferred insulinsapidra, Humulin, Humalog, Humalog Mix and Afrezza will move to tier 4. Members on non-preferred insulin products should contact their physician aboutusing a preferred insulin product. Medical necessity utilization management criteria will be implemented to encourage the use of preferred products: Novolin, Novolog or Novolog Mix. If the member uses a non-preferred drug, he/she will need to obtain prior authorization approval. Members will need to convert to One Touch, the preferred blood glucose product.members on non-preferred products will receive instructions and ongoing communications on how to acquire a new glucose meter at no additional cost. Those using insulin pumps will not be required to change strips if they are not compatible. Effective Date July 31, 2015 January 1, 2016 January 1, 2016 ADHD utilization management programchanges Q: How is Wellmark enhancing its current ADHD utilization management program, and when will it be effective? A: Wellmark will enhance its current ADHD utilization management program with the following: Management Changes Effective Date 6/15 Page 5 of 7
6 Strategy Add quantity limits Require prior authorization For members safety, Wellmark will add quantity limits on all stimulant drugs regardless of age to ensure maximum daily dosing recommendations are followed. Wellmark will now apply prior authorization criteria to adults, age 18 years and older, for both brand and generic long-acting stimulants. The change will encourage clinically appropriate utilization of these medications and direct members to try generic immediaterelease stimulants first before moving on to the more costly alternatives. August 15, 2015 August 15, 2015 Compound management program changes Q: How is Wellmark enhancing its compound management program, and when will it be effective? A: In response to rising costs for compound drugs and for the safety of our members, Wellmark developed a compound management strategy. Management Strategy Evaluatecompound ingredients to identify needless cost and waste Require prior authorization for compound medications that exceed $500 Changes With members safety in mind, Wellmark will not cover compounds containing vitamins, minerals, over-the-counter and non-fdaapproved ingredients, compounds for cosmetic use, or compounds for performance enhancement. The criteria applies when compounds are used in accordance with FDA-approved indications, supported uses,and when they are administered using current, accepted practice guidelines. This will contain costs and, most importantly, keep your employees safe. Effective Date July 31, 2015 January 1, 2016 Q: Why are these changes necessary? A: By continuously monitoring for clinically unproven ingredients used in compound medications, the program will eliminate unnecessary spend for these medications while ensuring member safety. Q: What if a compound drug is medically necessary? 6/15 Page 6 of 7
7 A: Wellmark recommends youcontinue to cover the types of compounds that members need when covered by their pharmacy benefits. However, generally, compound medications do not provide additional clinical value over what is commercially available and FDA approved. For more information Q: Areadditionaleducational materials available about these changes? A: These drug updates may be challenging to understand, but Wellmark and your account manager are here to help. Wellmark created fact sheets that provide high-level information on these updates. Please speak to your account manager to obtain these communications. More communications on these updates will be available through the summer and fall. As always, your account manager will answer additional questions. Q: Where shouldmy employees go for more information about these drug changes? A: If your employees have questions about the changes to thesedrug policies, they are encouraged to call Wellmark Customer Servicevia the number on the back of their ID card. 6/15 Page 7 of 7
Part D Pharmacy. An Independent Licensee of the Blue Cross Blue Shield Association ( )
Part D Pharmacy 1 An Independent Licensee of the Blue Cross Blue Shield Association 044507 (12-21-2017) New MA pharmacy partner We ve selected CVS Caremark to manage our part D pharmacy benefits Providence
More informationPharmacy Trends and Management Opportunities. Kerry Bendel, R.Ph. Director of Pharmacy Medica
Pharmacy Trends and Management Opportunities Kerry Bendel, R.Ph. Director of Pharmacy Medica September 14, 20 1 Agenda Pharmacy Trend Experience Trend Drivers and Management Opportunities Call to Action
More informationOregon Health Plan prescription benefit updates
Oregon Health Plan prescription benefit updates EOCCO s prescription program is a pharmacy benefit that offers members a choice of safe and effective medication treatments. The program also helps you save
More informationFormulary Medical Necessity Program
BENEFIT APPLICATION Formulary Medical Necessity Program DRUG POLICY Benefit determinations are based on the applicable contract language in effect at the time the services were rendered. Exclusions, limitations
More informationFlexRx 6-Tier. SM Pharmacy Benefit Guide
FlexRx 6-Tier SM Pharmacy Benefit Guide Welcome to FlexRx The AllWays Health Partners FlexRx SM program is built for choice, savings, and convenience with benefits including: Low-cost drug tier for many
More informationPrescription benefit updates Large group
Prescription benefit updates Large group Moda Health s prescription program is a pharmacy benefit that offers members a choice of safe effective medication treatments. The program also helps you save money
More informationPharmacy benefit guide
FlexRx SM 5-Tier Pharmacy benefit guide 1 Welcome to FlexRx The NHP FlexRx SM program is built for choice, savings, and convenience with benefits including: Low-cost drug tier for many common medications
More informationPrescription Benefit Management. Eric Cannon, PharmD, FAMCP
Prescription Benefit Management Eric Cannon, PharmD, FAMCP Agenda Drugs as a Share of Health Spending Top Drugs of 2016 Management Interventions and Strategies Specialty Pharmacy, Generics and Biologics
More informationStep Therapy Criteria
Tier 5 Formulary Step Therapy 2016 Updated: 05/24/2016 Effective: 06/01/2016 What is Step Therapy? Some prescription drugs require step therapy (ST). In some cases, the plan requires you to first try certain
More informationInsulins: Prices, Rebates, and Other Factors Influencing Costs. May 2018
Insulins: Prices, Rebates, and Other Factors Influencing Costs May 2018 Introduction: Types of Insulin Types of Insulin Rapid-acting: Usually taken before a meal to cover the blood glucose elevation from
More informationCoverage Period: 01/01/ /31/2018 Coverage for: Individual and/or Family Plan: Healthy Rewards HSA
This is only a summary of your GatorCare pharmacy benefits. If you would like detail about your coverage and costs, you can get the complete terms in the policy or plan document at gatorcare.magellanrx.com/member
More informationHARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES
Generic Brand HICL GCN Exception/Other BLOOD SUGAR DIAGNOSTIC DIABETIC TEST STRIPS 25200 NOTE: Requests for preferred blood glucose (diabetic) test strips manufactured by Abbott Diabetes Care (such as
More informationJOIN IN AN UNPRECEDENTED STATEWIDE MOVEMENT TO CHANGE HEALTHCARE
JOIN IN AN UNPRECEDENTED STATEWIDE MOVEMENT TO CHANGE HEALTHCARE PASBO S STATEWIDE DATA STRATEGY WITH INNOVU PASBO 62 ND ANNUAL CONFERENCE AND EXHIBITS, PITTSBURGH 1 DATA STRATEGY PLATFORM 2 1 WHAT ARE
More informationClinical Policy: Natalizumab (Tysabri) Reference Number: ERX.SPA.162 Effective Date:
Clinical Policy: (Tysabri) Reference Number: ERX.SPA.162 Effective Date: 10.01.16 Last Review Date: 11.17 Revision Log See Important Reminder at the end of this policy for important regulatory and legal
More informationCoverage Period: Coverage for: Plans: This is only a summary of your GatorCare pharmacy benefits. Coinsurance: you your Dependent Copayment: you
This is only a summary of your GatorCare pharmacy benefits. If you would like detail about your coverage and costs, you can get the complete terms in the policy or plan document at gatorcare.magellanrx.com/member
More informationMedical Policy An Independent Licensee of the Blue Cross and Blue Shield Association
Ampyra (dalfampridine) Page 1 of 9 Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Title: Ampyra (dalfampridine) Prime Therapeutics will review Prior Authorization
More information2016 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan
2016 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan Plan Details, Programs, and Policies Table of Contents Click on the links below to be taken to that
More informationGetting started with Prime
Getting started with Prime How does a pharmacy plan work? When you visit your doctor, he or she may prescribe medicine for you. Here's how the plan works: Take your prescription and member ID card to the
More informationGet the most from your prescription plan
Get the most from your prescription plan THE BALTIMORE CITY PUBLIC SCHOOLS Introducing Express Scripts What s Inside Your plan at a glance...2 Generics Preferred program...2 Prior authorization...3 Quantity
More informationCase Study. GlucosePATH shows the way to improved outcomes and $1.1MM in employer drug cost savings
Case Study GlucosePATH shows the way to improved outcomes and $1.1MM in employer drug cost savings Background A self-insured company has 600 employees with Type 2 Diabetes The company asked if GlucosePATH
More information$250 (Deductible does not apply to Tier 1 and Tier 2) $500 (Deductible does not apply to Tier 1 and Tier 2)
Benefit Summary Outpatient Prescription Drug Illinois 5/50/100/250 Plan 455 Your Co-payment and/or Co-insurance is determined by the tier to which the Prescription Drug List (PDL) Management Committee
More information2018 Travelers Prescription Drug Plan High Deductible + HSA Plan
2018 Travelers Prescription Drug Plan High Deductible + HSA Plan Plan Details, Programs, and Policies Table of Contents Click on the links below to be taken to that section National Preferred Formulary
More informationClinical Policy: Natalizumab (Tysabri) Reference Number: ERX.SPA.162 Effective Date:
Clinical Policy: (Tysabri) Reference Number: ERX.SPA.162 Effective Date: 10.01.16 Last Review Date: 05.18 Revision Log See Important Reminder at the end of this policy for important regulatory and legal
More informationAPPENDIX D SASKATCHEWAN MS DRUGS PROGRAM
APPENDIX D SASKATCHEWAN MS DRUGS PROGRAM PROCEDURE FOR OBTAINING COVERAGE OF MS DRUGS UNDER THE DRUG PLAN Requests are initiated by a physician. The patient and physician complete the application form
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Tysabri) Reference Number: HIM.PA.SP17 Effective Date: 05.01.17 Last Review Date: 05.18 Line of Business: Health Insurance Marketplace Coding Implications Revision Log See Important Reminder
More informationMedication Policy Manual. Topic: Tecfidera, dimethyl fumarate Date of Origin: May 16, 2013
Medication Policy Manual Policy No: dru299 Topic: Tecfidera, dimethyl fumarate Date of Origin: May 16, 2013 Committee Approval Date: December 16, 2016 Next Review Date: December 2017 Effective Date: January
More informationGranite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18
Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18 Granite Alliance requires step therapy for certain drugs. This means prior to receiving a drug with a step therapy
More informationPharmaceutical Management Medicaid 2019
Pharmaceutical Management Medicaid 2019 Toll-free Contact Number: (888) 327-0671 Pharmacy Administration: (810) 244-1660 Introduction Pharmaceutical Management promotes the use of the most clinically appropriate,
More information2. Has this plan authorized this medication in the past for this member (i.e., previous authorization is on file under this plan)?
Pharmacy Prior Authorization AETA BETTER HEALTH EW JERSE (MEDICAID) Multiple Sclerosis (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information,
More informationGet the most from your prescription plan
Get the most from your prescription plan THE BALTIMORE CITY PUBLIC SCHOOLS Introducing Express Scripts What s Inside Your plan at a glance...2 Generics Preferred program...2 Prior authorization...3 Quantity
More informationDRUG TREND REPORT. WellDyneRx ANNUAL 1 2% 34% WellDyneRx. Diabetes MS Oncology Asthma/COPD HIV. Pain/inflammation. High Blood Choles Attention Disorde
WellDyneRx 34% 1 2% Inflammatory Con Diabetes MS Oncology Asthma/COPD High Blood Pressu HIV Pain/inflammation High Blood Choles Attention Disorde Inflammatory Con Diabetes MS Oncology Asthma/COPD High
More informationPharmacy Prior Authorization
Pharmacy Prior Authorization AETA BETTER HEALTH VIRGIIA Multiple Sclerosis Agents (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information,
More informationBLUE SHIELD OF CALIFORNIA JUNE 2016 PLUS DRUG FORMULARY CHANGES
BLUE SHIELD OF CALIFORNIA JUNE 2016 PLUS DRUG FORMULARY CHANGES Blue Shield is committed to covering safe, effective and affordable medications, so we regularly review and update our drug formularies.
More informationDIABETES (1 of 5) Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10. Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10 $0 $0 $0
Metformin DIABETES (1 of 5) Glucophage Glucophage XR ER $7 (500mg) $7 (500mg) $5 $5 500mg, 750mg only 500mg, 750mg only Sulfonylurea/Combinations Amaryl Glucotrol glimepiride glipizide $5 $5 Glucotrol
More informationRationale for Decision Excluded Generic OTC equivalent available (Flonase Allergy Relief) Medicare status (if differs)
BLUE SHIELD OF CALIFORNIA FIRST QUARTER 2015 FORMULARY AND MEDICATION POLICY UPDATES EFFECTIVE MARCH 19, 2015 The Blue Shield of California (BSC) Pharmacy and Therapeutics (P&T) Committee, consisting of
More information2. Has this plan authorized this medication in the past for this member (i.e., previous authorization is on file under this plan)?
Pharmacy Prior Authorization MERC CARE (MEDICAID) Multiple Sclerosis (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign and
More informationPHARMACY BENEFITS MANAGER
PHARMACY BENEFITS MANAGER CU GME Benefits Office Prescriptions should be obtained at participating pharmacies using your Benefits ID card. A list of participating pharmacies may be obtained by calling
More informationHARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES
Generic Brand HICL GCN Exception/Other INSULIN REGULAR, HUMAN AFREZZA 37619, 37622, 37623, 38923, 37624, 42833, 38918, 37621 GUIDELINES FOR USE 1. Is the member currently taking the requested medication
More informationClinical Policy: Natalizumab (Tysabri) Reference Number: ERX.SPA.162 Effective Date:
Clinical Policy: (Tysabri) Reference Number: ERX.SPA.162 Effective Date: 10.01.16 Last Review Date: 11.18 Revision Log See Important Reminder at the end of this policy for important regulatory and legal
More information2. Has this plan authorized this medication in the past for this member (i.e., previous authorization is on file under this plan)?
Pharmacy Prior Authorization AETA BETTER HEALTH KETUCK Multiple Sclerosis Agents (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information,
More informationSTEP THERAPY IN MEDICARE PART D
STEP THERAPY IN MEDICARE PART D Sarkis Kavarian, PharmD Candidate 15 Preceptor Dr. Craig Stern Pro Pharma Pharmaceutical Consultants, Inc. May 1 st, 2015 Objectives Why is this important? Medicare Part
More informationSave on your drugs with HealthyRx
Save on your drugs with HealthyRx HealthyRx is a savings program offered through the UVa Hoo s Well program. It helps lower your costs on drugs for certain health conditions. Effective 4/1/17, you are
More informationAMPYRA (dalfampridine) extended release oral tablet Dalfampridine ER oral tablet
Dalfampridine ER oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage
More informationDear Member: We look forward to serving you. Sincerely, Express Scripts
Dear Member: Welcome to Express Scripts, the company Eastern Kentucky University has chosen to manage your prescription drug plan. As one of the nation s leading prescription benefit managers, Express
More informationUnderstanding the Value of Generic Drugs
Understanding the Value of Generic Drugs Generic drugs can help you get the most out of your health care budget. 05.02.306.1 (8/05) Many people believe that when something costs more, it must be of higher
More informationSpecialty conditions overview
Specialty conditions overview Prevalence and cost Click on the vials to learn more about these specialty conditions. 1. Approximate annual AWP cost per patient of top utilized drugs for UHC calendar year
More informationSpecialty Drugs in Workers Compensation
Specialty Drugs in Workers Compensation A GUIDE FOR CLAIMS HANDLERS Specialty Drugs Specialty drugs have been developed in response to demand for specialized medications for complex medical conditions.
More informationF Y 1 8 U T I L I Z A T I O N R E V I E W 7/1/2017 TO 3/31/2018 L O C K T O N C O M P A N I E S
UNIVERSITY OF ALASKA F Y 1 8 U T I L I Z A T I O N R E V I E W 7/1/2017 TO 3/31/2018 L O C K T O N C O M P A N I E S Premera - Medical L O C K T O N C O M P A N I E S Medical Utilization % Change Norm
More informationClinical Policy: Natalizumab (Tysabri) Reference Number: CP.PHAR.259 Effective Date: Last Review Date: Line of Business: Medicaid
Clinical Policy: (Tysabri) Reference Number: CP.PHAR.259 Effective Date: 07.01.16 Last Review Date: 05.18 Line of Business: Medicaid Coding Implications Revision Log See Important Reminder at the end of
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Tysabri) Reference Number: HNMC.CP.PHAR.259 Effective Date: 07.01.16 Last Review Date: 05.18 Line of Business: Medicaid Medi-Cal Coding Implications Revision Log See Important Reminder
More informationPHARMACY Section 9. Overview. Preferred Drug List. Additions and Exceptions to the Preferred Drug List
Overview The management of outpatient prescription drugs is an integral part of the medical management program to improve the health and well-being of our members. Prescriber and member involvement is
More informationSafe, effective, affordable drug choices: online tool for payers and patients.
Executive summary: Rising healthcare costs and greater access to medical information drive patients to seek options for their drug therapy. The MedAlternatives database by Gold Standard/Elsevier empowers
More informationANGIOTENSIN RECEPTOR BLOCKERS
Step Therapy 2014 2 Tier-Alameda Last Updated: 10/10/2014 ANGIOTENSIN RECEPTOR BLOCKERS Benicar Benicar Hct Diovan Valsartan Step 1: First line therapy should be irbesartan, irbesartan/hctz, losartan,
More informationF Y 1 9 U T I L I Z A T I O N R E V I E W 7/1/2018 TO 9/30/2018 L O C K T O N C O M P A N I E S
UNIVERSITY OF ALASKA F Y 1 9 U T I L I Z A T I O N R E V I E W 7/1/2018 TO 9/30/2018 L O C K T O N C O M P A N I E S Premera- Medical L O C K T O N C O M P A N I E S Medical Utilization % Change Norm FY18
More informationYour Prescription Card. Your guide for savings.
3 Paragon Drive Montvale, NJ 07645 >00001 00001 001 P50708 _PM 7873 GROUP JOHN Q SAMPLE 9501 E. Shea Blvd SCOTTSDALE, AZ 85260 APDNCLDJDKDIFPAKHPANEMFK AJCLLKEBEKNJJBNMPKGOKIKK AMBPIBPEAKHEIOBKFGFBOMMK
More information4/2/2018. Easing the pharmacy experience and stretching the diabetes dollar. Alyson Blum, PharmD, CDE. I have no conflicts of interest to disclose
Easing the pharmacy experience and stretching the diabetes dollar. Alyson Blum, PharmD, CDE Clinical Pharmacist in Obstetrics Center for Maternal Fetal Medicine at Sacred Heart Medical Center Clinical
More informationRECEIVING YOUR PERMANENT
00001 JOHN Q SAMPLE 9501 E. Shea Blvd SCOTTSDALE, AZ 85260 3118-00001_PM City of Savannah 132 E. Broughton Street Savannah, GA 31401 THIS IS A ONE-TIME CARD TO BE USED UNTIL YOUR PERMANENT CARD ARRIVES
More informationPharmacy Management Drug Policy
SUBJECT: Multiple Sclerosis, Crohn s Disease POLICY NUMBER: PHARMACY-53 EFFECTIVE DATE: 4/08 LAST REVIEW DATE: 12/18/2018 If the member s subscriber contract excludes coverage for a specific service or
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Tysabri) Reference Number: HIM.PA.SP17 Effective Date: 05.01.17 Last Review Date: 11.18 Line of Business: Health Insurance Marketplace Coding Implications Revision Log See Important Reminder
More informationOptumRx Focused Utilization Management Program
Utilization management updates - January 1, 2019 OptumRx Focused Utilization Management Program OptumRx focused step therapy with quantity limits programs If you have a prescription for any of the Step
More informationCoventry Health Care of Georgia, Inc.
Coventry Health Care of Georgia, Inc. PRESCRIPTION DRUG RIDER (for High Deductible Health Plans) This Prescription Drug Rider is an attachment to the Coventry Health Care of Georgia, Inc. ( Health Plan
More informationAmerigroup Washington, Inc. to conduct postservice reviews of certain modifiers and services
Provider News Bulletin Amerigroup Washington, Inc. https://providers.amerigroup.com/ Medicaid providers: 1-800-454-3730 Medicare providers: 1-866-805-4589 December 2017 Table of Contents Special Announcement:
More informationYour Prescription Card. Your guide for savings.
CVS Caremark 620 Epsilon Drive Pittsburgh, PA 15238 4750-_PM 9501 E. Shea Blvd SCOTTSDALE, AZ 85260 Your Prescription Card. Your guide for savings. Dear Plan Member, Welcome to your new benefits. Attached
More informationPATIENT PREPAREDNESS PLAN
PATIENT PREPAREDNESS PLAN DO YOU OR A LOVED ONE HAVE DIABETES AND USE INSULIN? Make a plan to stay healthy during natural disaster or emergency Managing diabetes can be even harder when you are dealing
More informationCollaborative Practice Agreement
Collaborative Practice Agreement [community pharmacy name] [address] [phone number] [physician practice] [address] [phone number] Effective: [date] Expiration: [date] 1 Table of Contents 1.0 Introduction...4
More informationIHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT NOVEMBER 30, 2010
IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201056 NOVEMBER 30, 2010 Changes to the Preferred Drug List Changes to the Preferred Drug List (PDL) were made at the November 19, 2010, Drug Utilization
More informationNew Generics: Specialty Network: Retail Pharmacies Dispensing Specialty Products
SUPPORTING OUR PROVIDER PARTNERS THROUGH COMMUNICATION AND COLLABORATION. DATE JANUARY 2016 ISSUE 1 HELPFUL NUMBERS FOR PROVIDERS Magellan: 1-800-846-7971 Bin: 016523 Processor control: 747 HELPFUL NUMBERS
More informationSpending on Individuals with Type 1 Diabetes and the Role of Rapidly Increasing Insulin Prices
Spending on Individuals with Type 1 Diabetes and the Role of Rapidly Increasing Insulin Prices Authors: Jean Fuglesten Biniek William Johnson January 2019 Insulin Prices Were the Primary Driver of Rapid
More informationIssues for Part D Compliance
HCCA- MEDICARE PRESCRIPTION DRUG PART D COMPLIANCE CONFERENCE Issues for Part D Compliance Craig Miner, RPh, JD Division of Drug Plan Policy Babette S. Edgar, Pharm.D., MBA Division of Finance and Operations
More informationMAXIMUM ALLOWABLE COST POLICY CHANGES DECEMBER 5, 2016 QUESTIONS AND ANSWERS
MAXIMUM ALLOWABLE COST POLICY CHANGES DECEMBER 5, 2016 QUESTIONS AND ANSWERS The November 22, 2016 Mid-Year Financial Report referred to changes to drug coverage under the Saskatchewan Drug Plan. What
More informationDate: October 3, 2017 To: Participating Providers From: YourCare Health Plan Provider Relations Subject: 2018 Formulary Changes
Date: October 3, 2017 To: Participating Providers From: YourCare Health Plan Provider Relations Subject: 2018 Formulary Changes 2018 Formulary-UM Changes What does this mean now, and for 2018? A number
More informationADMELOG, NOVOLIN, NOVOLOG, and FIASP
ADMELOG, NOVOLIN, NOVOLOG, and FIASP Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy
More informationTexas Prior Authorization Program Clinical Edit Criteria
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization
More informationpresents How to S.E.A.R.C.H. for the Right MS Therapy for You! G Live Webinar October 19, 2016
presents How to S.E.A.R.C.H. for the Right MS Therapy for You! G Live Webinar October 19, 2016 How to S.E.A.R.C.H. for the Right MS Therapy for You! Guest Presenter Carrie M. Hersh, DO, MS MS Neurologist
More informationCommercial Formulary and Utilization Management Program Updates for January 2017 Producer Communication #782 Issued November 10, 2016
Commercial and Utilization Management Program Updates for January 2017 Producer Communication #782 Issued November 10, 2016 Message The Capital BlueCross Pharmacy & Therapeutics (P&T) Committee, consisting
More informationPharmacy Medical Policy Natalizumab (Tysabri )
Pharmacy Medical Policy Natalizumab (Tysabri ) Table of Contents Policy: Commercial Information Pertaining to All Policies Endnotes Coding Information References Forms Policy History Policy Number: 062
More informationTexas Prior Authorization Program Clinical Edit Criteria
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Thiazolidinediones Clinical Edit Information Included in this Document Thiazolidinediones Drugs requiring prior authorization: the
More informationRegulatory Status FDA-approved indication: Tysabri is an integrin receptor antagonist indicated for treatment of:
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.08.27 1 of 6 Last Review Date: December 5, 2014 Tysabri Description Tysabri (natalizumab) Background
More information2014 Quantity Limits (QL) Criteria
2014 Quantity Limits (QL) Criteria Certain drugs covered through your EmblemHealth Medicare HMO/PPO Medicare Plan are covered for only a limited quantity. We do this to ensure compliance with the US Food
More informationEXAMPLE ONLY. RxBIN Issuer (80840) ID NAME Drew Zehnder. Houston Methodist 6565 Fannin Street, GB164 Houston, TX 77030
Houston Methodist 6565 Fannin Street, GB164 Houston, TX 77030 00001 RxBIN 004336 RxPCN ADV RxGRP RX3151 Issuer (80840) 9151014609 ID NAME 111111111 Drew Zehnder Present this Prescription Card to fill your
More informationClinical Policy: Mitoxantrone (Novantrone) Reference Number: CP.CPA.334 Effective Date: Last Review Date: Line of Business: Commercial
Clinical Policy: (Novantrone) Reference Number: CP.CPA.334 Effective Date: 06.01.18 Last Review Date: 05.18 Line of Business: Commercial Coding Implications Revision Log See Important Reminder at the end
More informationFree Yourself Tips for living without back pain
spring 2010 Free Yourself Tips for living without back pain - Log on to live healthier - Diabetes do s and don ts - How to appeal a claim best friends enjoying Idaho's city of rocks one TO one newsletter
More informationWhat do you need to know before you go home?
What do you need to know before you go home? What is Insulin Types of Insulin Injection Sites How to Inject Insulin Correctly Low Blood Sugar and Treatment Sick Day Management After leaving the Hospital:
More informationBLOOD GLUCOSE METER TEST STRIP STEP THERAPY CRITERIA
BLOOD GLUCOSE METER TEST STRIP STEP THERAPY CRITERIA Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan.
More informationUpdate to HMO Drug Formulary Tier Definitions. February 8, 2018
Update to HMO Drug Formulary Tier Definitions February 8, 2018 Agenda 1 Overview of Current Drug Tiers 2 Proposed Drug Tiers for 2019 3 Impact to SFHSS and SFHSS Members 4 How the Drug Formulary Works
More informationClinical Policy: Mitoxantrone (Novantrone) Reference Number: CP.PHAR.258 Effective Date: Last Review Date: Line of Business: Medicaid
Clinical Policy: (Novantrone) Reference Number: CP.PHAR.258 Effective Date: 08.01.16 Last Review Date: 05.18 Line of Business: Medicaid Coding Implications Revision Log See Important Reminder at the end
More informationMedication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012
Medication Policy Manual Policy No: dru283 Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012 Committee Approval Date: December 16, 2016 Next Review Date: December 2017 Effective Date: January
More informationPHARMACY BENEFITS MANAGER SELECTION FAQ FOR PRODUCERS
PHARMACY BENEFITS MANAGER SELECTION FAQ FOR PRODUCERS For Producer Audience Only - Please Do Not Distribute Regence has selected Prime Therapeutics as the Pharmacy benefits manager for its health plans.
More information1, 2014 PHARMACY BENEFIT
Effective 01/01/2007City of Plano Employee Benefit Design Summary Effective Date: January 1, 2014 PHARMACY BENEFIT CVS/CAREMARK TOLLFREE: 888-850-8245 ID CARD & NETWORK PHARMACIES: Identification Card
More informationUp to $402,000. Insight HIV. Drug Class. 1.2 million people in the United States were living with HIV at the end of 2011 (most recent data).
HIV Background, new developments, key strategies Drug Class Insight INTRODUCTION Human Immunodeficiency Virus (HIV) is the virus that can lead to Acquired Immunodeficiency Syndrome, or AIDS. No safe and
More informationConversion from lantus to tresiba
Conversion from lantus to tresiba Search dosages for Diabetes Type 2 and Diabetes Type 1; plus renal, liver and. Forecast your health care. Every time you have a symptom or are diagnosed of a condition,
More information2016 Drug Trend Report MEDICARE
2016 Drug Trend Report MEDICARE 2016 Drug Trend Report Medicare Introduction 3 Trend analysis 6 Keeping spending increases in check for America s seniors 7 Medicare Advantage Prescription Drug Plan (MAPD)
More informationWelcome to your. Pharmacy Services Guide. Many of our stores are open 24 hours. To find one near you, visit or call SHOP CVS.
Welcome to your Many of our stores are open 24 hours. To find one near you, visit www.cvs.com or call 1-800-SHOP CVS. Pharmacy Services Guide 06530RXS09 - Item #456748 11/08 Supplying you with health information
More informationFOR YOUR ADVOCATING DIABETES NEEDS. Moving Forward. DOI: By Melissa Lee and Martin Wood
ADVOCATING FOR YOUR DIABETES NEEDS By Melissa Lee and Martin Wood DOI: http://dx.doi.org/10.17125/plaid.2017.105 52 Vol. 3 No. 1 www.theplaidjournal.com Diabetes is expensive. The costs of diabetes-related
More informationClinical Policy: Natalizumab (Tysabri) Reference Number: CP.PHAR.259 Effective Date: Last Review Date: Line of Business: Medicaid
Clinical Policy: (Tysabri) Reference Number: CP.PHAR.259 Effective Date: 07.01.16 Last Review Date: 11.18 Line of Business: Medicaid Coding Implications Revision Log See Important Reminder at the end of
More information